Related Experiment Videos
Hodgkin disease in the elderly. A registry-based analysis
F L Erdkamp1, W P Breed, L J Bosch
1Department of Internal Medicine, Catharina Hospital, Eindhoven, The Netherlands.
Cancer
|August 15, 1992
Summary
Older Hodgkin disease patients face poorer survival due to inadequate treatment, not disease severity or intercurrent illnesses. Relapse-free survival remains comparable when remission is achieved, highlighting treatment access as key.
Area of Science:
- Oncology
- Geriatric Medicine
- Clinical Epidemiology
Background:
- Hodgkin disease survival declines with age, but causative factors remain unclear.
- Limited data exists on age-related prognostic effects in Hodgkin disease patients.
- Understanding these factors is crucial for improving geriatric oncology care.
Purpose of the Study:
- To identify factors contributing to the age-related decrease in survival for Hodgkin disease patients.
- To compare disease characteristics, treatment adequacy, and remission rates between older and younger patients.
- To analyze the impact of intercurrent diseases on survival in elderly Hodgkin disease patients.
Main Methods:
- Retrospective analysis of 182 nonselected Hodgkin disease patients.
- Comparison of survival curves based on age groups (over 50 vs. younger).
- Evaluation of treatment adequacy, complete remission rates, relapse-free survival, and intercurrent diseases.
Main Results:
- Survival time significantly decreased in patients over 50 years old.
- Older patients received less adequate treatment (34% vs. 2%) and achieved lower remission rates (61% vs. 90%).
- Relapse-free survival was similar for older and younger patients achieving complete remission; intercurrent disease impact was minimal.
Conclusions:
- Inadequate treatment is the primary reason for poorer overall survival in older Hodgkin disease patients.
- Age itself is not the main prognostic factor; treatment accessibility is critical.
- Strategies to improve treatment delivery for elderly Hodgkin disease patients are needed.